INSIG1 and metabolic dysfunction-associated steatotic liver disease: To determine whether SREBPs are protective or deleterious, we used an Insig1 KO mouse characterised by hyper-functional SREBP transcriptional activity that was subjected to a dietary challenge to model NAFLD.